FleishmanHillard Vanguard Held and GSK hold International Scientific Conference on Biomedicine

FleishmanHillard Vanguard supported GlaxoSmithKline, one of the world’s leading research companies and producers of medicines and health products, in organising a scientific conference at the British Embassy in Russia. The discussion focused on issues of international cooperation in the field of biomedicine.

Russian and British experts in the development of modern anti-cancer drugs and vaccines joined by experts of the World Health Organization (WHO) discussed the most important aspects of cooperation between the two countries. The speakers included Mrs. Barbara Habberdzham, Minister-Counsellor at the British Embassy in the Russian Federation, Dr. Moncef Slough, global head of research and development at GlaxoSmithKline and various Russian experts.

The meeting discussed the most effective examples of partnership between Russian and British universities, research groups and the research, technology and innovation business community.

GSK, one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.